Chou, S.-C.; Huang, C.-P.; Su, Y.-H.; Yu, C.-H.; Yang, Y.-L.; Wang, S.-C.; Lin, Y.-H.; Chen, Y.-T.; Li, J.-Y.; Chang, Y.-T.;
et al. Preclinical Evaluation of the Systemic Safety, Efficacy, and Biodistribution of a Recombinant AAV8 Vector Expressing FIX-TripleL in Hemophilia B Mice: Implications for Human Gene Therapy. Int. J. Mol. Sci. 2025, 26, 6073.
https://doi.org/10.3390/ijms26136073
AMA Style
Chou S-C, Huang C-P, Su Y-H, Yu C-H, Yang Y-L, Wang S-C, Lin Y-H, Chen Y-T, Li J-Y, Chang Y-T,
et al. Preclinical Evaluation of the Systemic Safety, Efficacy, and Biodistribution of a Recombinant AAV8 Vector Expressing FIX-TripleL in Hemophilia B Mice: Implications for Human Gene Therapy. International Journal of Molecular Sciences. 2025; 26(13):6073.
https://doi.org/10.3390/ijms26136073
Chicago/Turabian Style
Chou, Sheng-Chieh, Cheng-Po Huang, Ying-Hui Su, Chih-Hsiang Yu, Yung-Li Yang, Ssu-Chia Wang, Yi-Hsiu Lin, Yen-Ting Chen, Jia-Yi Li, Yen-Ting Chang,
and et al. 2025. "Preclinical Evaluation of the Systemic Safety, Efficacy, and Biodistribution of a Recombinant AAV8 Vector Expressing FIX-TripleL in Hemophilia B Mice: Implications for Human Gene Therapy" International Journal of Molecular Sciences 26, no. 13: 6073.
https://doi.org/10.3390/ijms26136073
APA Style
Chou, S.-C., Huang, C.-P., Su, Y.-H., Yu, C.-H., Yang, Y.-L., Wang, S.-C., Lin, Y.-H., Chen, Y.-T., Li, J.-Y., Chang, Y.-T., Chen, S.-Y., & Lin, S.-W.
(2025). Preclinical Evaluation of the Systemic Safety, Efficacy, and Biodistribution of a Recombinant AAV8 Vector Expressing FIX-TripleL in Hemophilia B Mice: Implications for Human Gene Therapy. International Journal of Molecular Sciences, 26(13), 6073.
https://doi.org/10.3390/ijms26136073
